CytomX Therapeutics CTMX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 4.26 | 105.58 | 25.76 | -0.22 | -27,932 | -27 |
| 2025Q3 | 3.19 | 111.27 | 10.96 | -0.14 | -15,768 | -14 |
| 2025Q2 | 2.27 | 1427.78 | 4.40 | -0.06 | -1,285 | 0 |
| 2025Q1 | 0.64 | 95.90 | 1.22 | 0.27 | 22,621 | 24 |
| 2024Q4 | 1.03 | 93.35 | 2.53 | 0.23 | 17,679 | 19 |
| 2024Q3 | 1.18 | 70.92 | 6.67 | 0.06 | 4,111 | 6 |
| 2024Q2 | 1.22 | 130.39 | 5.75 | -0.08 | -8,452 | -7 |
| 2024Q1 | 2.18 | 84.23 | 0.17 | 11,657 | 14 | |
| 2023Q4 | 1.55 | -31.79 | 0.01 | -606 | 1 | |
| 2023Q3 | 1.29 | 53.71 | 0.05 | 3,123 | 3 | |
| 2023Q2 | 1.72 | 308.00 | -0.02 | -3,348 | -1 | |
| 2023Q1 | 1.51 | 170.73 | -0.05 | -5,653 | -3 | |
| 2022Q4 | 1.60 | 108.35 | -0.13 | -9,508 | -9 | |
| 2022Q3 | 1.45 | 106.53 | -0.44 | -10,534 | -10 | |
| 2022Q2 | 1.83 | 103.47 | -0.45 | -16,646 | -16 | |
| 2022Q1 | 2.67 | 100.34 | -0.49 | -23,966 | -24 | |
| 2021Q4 | 4.33 | 100.31 | -0.40 | -26,308 | -26 | |
| 2021Q3 | 5.09 | 100.25 | -0.35 | -22,641 | -23 | |
| 2021Q2 | 6.33 | 99.80 | -0.29 | -19,205 | -19 | |
| 2021Q1 | 7.73 | 100.47 | -0.26 | -15,627 | -16 |